Lai Wong
Vermögen: 37 655 $ am 31.05.2026
Vermögen: 37 655 $ am 31.05.2026
Lai Wong currently works at CIMC Enric Holdings Ltd., as Independent Non-Executive Director from 2023, ENN Energy Holdings Ltd., as Independent Non-Executive Director from 2023, Binhui Biopharmaceutical Co., Ltd., as Independent Non-Executive Director from 2025, and Transpac Capital Ltd., as Partner.
Ms. Wong received her undergraduate degree from London Metropolitan University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.11.2025 | 34’000 ( 0% ) | 37 655 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ENN ENERGY HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 25.08.2023 |
| CIMC ENRIC HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 24.08.2023 |
Transpac Capital Ltd. | Corporate Officer/Principal | - |
Wuhan Binhui Biopharmaceutical Co., Ltd.
Wuhan Binhui Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer immunotherapies | Direktor/Vorstandsmitglied | 16.09.2025 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
CIMC Enric Holdings Ltd.
CIMC Enric Holdings Ltd. Industrial MachineryProducer Manufacturing Operates as a holding company whose subsidiaries manufactures and wholesales equipment for the storage, transportation, processing and distribution of natural gas | Producer Manufacturing |
ENN Energy Holdings Ltd.
ENN Energy Holdings Ltd. Gas DistributorsUtilities Distributes natural gas and energy | Utilities |
London Metropolitan University
London Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transpac Capital Ltd. | |
Wuhan Binhui Biopharmaceutical Co., Ltd.
Wuhan Binhui Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen